The Treatment of Angina Pectoris

Abstract

BEGINNING with the preparation of theobromine sodium salicylate in 1894¹ and erythrol tetra-nitrate in 1895,² many new measures have been advocated for the prevention of attacks of angina pectoris. The efficacy of each has been substantiated, apparently, by sound theoretical considerations, good laboratory results, impressive clinical evidence or combinations of all three. In clinical practice, however, the physician finds that the excellent clinical response in some patients is contrasted by questionable results or complete failures in others. Furthermore, equally good results have been reported to follow the administration of placebos. Certainly, no therapeutic measure advocated to date can be accepted . . .